Proton vs. Photon Radiation for Breast Cancer After Surgery
Part of Cancer, Skin clinical trials.
This study compares two types of radiation therapy—proton and photon—after breast cancer surgery to see which causes fewer side effects. Both are advanced treatments, and this trial helps doctors understand which might be safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Female, age 18 or older
- Diagnosed with invasive breast cancer or ductal carcinoma in situ (early-stage cancer in the milk ducts)
- Already had breast-conserving surgery or mastectomy, with or without breast reconstruction
- Doctor recommends radiation therapy after surgery
- Good overall health (able to carry out daily activities with minimal help)
- Expected to live at least 5 more years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing two types of radiation therapy—proton therapy and standard photon therapy—for people with left-sided breast cancer who need radiation after surgery. The goal is to find out which method best protects the heart while effectively treating the cancer.
This trial is testing how well two different radiation techniques, IMPT and IMRT, work for treating breast cancer. It aims to see which one is safer and more effective, so you might benefit from a potentially better treatment approach.
This trial studies a type of radiation made with proton beams given after mastectomy and implant reconstruction to lower breast cancer coming back. It’s for people who need additional (adjuvant) radiation and have not had prior radiation to the chest or breast.
This study compares two types of proton radiation after lumpectomy for early breast cancer. It tests whether a shorter, stronger course (ultra-hypofractionated) works as well as a slightly longer moderate course.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This trial compares two ways of giving radiation to the breast/chest wall and nearby lymph nodes after breast surgery: a standard schedule versus a shorter “hypofractionated” schedule. It uses proton therapy and may help reduce treatment time while still controlling the cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.